Inpatient Endoscopy Procedure Planning Delays and Impact on Length of Stay and 30-day Readmission (Impatience)

April 3, 2023 updated by: Radboud University Medical Center
Single center retrospective cohort study of all inpatient endoscopy procedures to asses factors associated with inpatient endoscopy delays and impact on length of stay and 30-day readmission

Study Overview

Detailed Description

Background: Delays in inpatient endoscopy planning negatively influence the quality and accessibility of care. This may result in higher healthcare costs, negative health outcomes, and unnecessary readmissions and use of hospital beds. Additionally, prolonged hospital stay is associated with poorer health outcomes and risk of nosocomial infections, amongst others.

Objective: To asses factors associated with inpatient endoscopy delays and impact on length of stay and 30-day readmission

Study design: Single center retrospective cohort study of all inpatient endoscopy procedures (gastroscopy, colonoscopy, ERCP, sigmoidoscopy) during 2016-2022. Data will be identified and extracted using CTCue. Only pseudonymized data will be used. Inpatient endoscopy delay will be defined as the number of days between the planned date versus the actual date. Multivariable logistic regression models will be performed to assess factors associated with inpatient endoscopy delay.

Study Type

Observational

Enrollment (Anticipated)

3700

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Gelderland
      • Nijmegen, Gelderland, Netherlands, 6525GA
        • Radboud University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult inpatients from all hospital departments undergoing endoscopy procedures. Patients will be selected via CTCue, with an admission based query that selects all adult patients with an admission of at least two days between 1-1-2014 and 1-12-2022 AND an endoscopic care activity.

Description

Inclusion Criteria:

  • Adult patients (>18 years)
  • Clinical admission in any hospital department of at least two days during 1 January 2016 and 1 December 2022
  • Endoscopic procedure during clinical admission, including gastroscopy, endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), flexible sigmoidoscopy, colonoscopy

Exclusion Criteria:

  • Elective admission
  • Procedure only for insertion of nasogastric or nasojejunal (feeding) tube without any other diagnostic or therapeutic aims

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of inpatient endoscopy delays (IED)
Time Frame: at endoscopic procedure
IED will be defined as the number of days between the planned date versus the actual date.
at endoscopic procedure
Difference in type of endoscopic procedure between patients with and without IED
Time Frame: at endoscopic procedure
Type of endoscopic procedure: gastroscopy/colonoscopy/endoscopic retrograde cholangio-pancreaticography (ERCP)
at endoscopic procedure
Difference in type of sedation between patients with and without IED
Time Frame: at endoscopic procedure
Type of sedation during endoscopic procedure: No sedation/conscious sedation/general anesthesia
at endoscopic procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Median length of hospital stay
Time Frame: through study cohort period from 1 january 2016 until 31 december 2022
length of hospital admission in days
through study cohort period from 1 january 2016 until 31 december 2022
rate of 30-day readmissions
Time Frame: up to 30 days
percentage of readmissions within 30 days after initial discharge
up to 30 days
Odds ratio of presence of inpatient endoscopy delays for risk of prolonged length of hospital stay and 30-day readmissions
Time Frame: from admission till 30 days after discharge
multivariable logistic regression modelling to assess factors associated with both outcomes and the impact of inpatient endoscopy delay
from admission till 30 days after discharge
Odds ratio of presence of inpatient endoscopy delays for risk of 30-day readmissions
Time Frame: from admission till 30 days after discharge
multivariable logistic regression modelling to assess factors associated with both outcomes and the impact of inpatient endoscopy delay
from admission till 30 days after discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Peter Siersema, MD, PhD, Radboud University Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 1, 2023

Primary Completion (Anticipated)

June 30, 2023

Study Completion (Anticipated)

June 30, 2023

Study Registration Dates

First Submitted

January 8, 2023

First Submitted That Met QC Criteria

April 3, 2023

First Posted (Actual)

April 4, 2023

Study Record Updates

Last Update Posted (Actual)

April 4, 2023

Last Update Submitted That Met QC Criteria

April 3, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2023-16151

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

IPD will be shared upon reasonable request

IPD Sharing Time Frame

15 years after publication date

IPD Sharing Access Criteria

supporting information will be shared upon reasonable request

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Readmission

Clinical Trials on Inpatient gastrointestinal endoscopy

3
Subscribe